David W. Dodick, MD
Advertisement
Director, Concussion and Headache Programs, Mayo Clinic; Chair, American Brain Foundation, IHS-Global Patient Advocacy Coalition
Articles by David W. Dodick, MD
Here: highlights from a systematic review that these authors view as a substantial step forward in establishing an evidence-based approach to migraine treatment in the acute care setting.
Advertisement
Latest Updated Articles
Therapies in Development for Acute MigrainePublished: October 30th 2020 | Updated:
Gepants for Acute Migraine: Safety & Efficacy DataPublished: October 30th 2020 | Updated:
Treating Acute Migraine in the Community SettingPublished: October 30th 2020 | Updated:
Advances in the Treatment of Acute MigrainePublished: October 30th 2020 | Updated:
Real-World Experience With Gepants for Acute MigrainePublished: October 30th 2020 | Updated:
Ubrogepant: Treatment for Acute MigrainePublished: October 30th 2020 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Therapeutic Potential and Early Promise Behind Stem Cell Therapy UX-DA001 in Parkinson Disease
2
BridgeBio Pursues FDA Submission for BBP-418 in LGMD2i/R9 After Positive Topline Phase 3 Results
3
Mechanism and Data Behind Scp776, a First-in-Class IGF-1-Based Therapy for Acute Ischemic Stroke
4
Fenebrutinib Hits Key Phase 3 Marks in Relapsing and Primary Progressive MS
5
